These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11276286)

  • 21. Education and imaging. Hepatobiliary and pancreatic: Portopulmonary hypertension with cirrhosis.
    Kasturi K; Rangasetty U
    J Gastroenterol Hepatol; 2008 Jan; 23(1):162. PubMed ID: 18171357
    [No Abstract]   [Full Text] [Related]  

  • 22. Portopulmonary hypertension in cirrhosis: the pathogenetic challenge.
    Wong F
    Gut; 2005 Feb; 54(2):309. PubMed ID: 15647202
    [No Abstract]   [Full Text] [Related]  

  • 23. [The clinical characteristics of antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension].
    Li C; Zhao JL; Liu S; Wang Q; Li MT; Zeng XF; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):198-201. PubMed ID: 30803178
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of primary antiphospholipid syndrome complicated with pulmonary hypertension].
    Rana M; Endo H; Watabe H; Tanaka S; Kondo H
    Ryumachi; 2001 Oct; 41(5):869-74. PubMed ID: 11729666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiphospholipid syndrome and the pneumologist].
    Piette JC; Cacoub P; Karmochkine M; Godeau P
    Rev Pneumol Clin; 1994; 50(3):99-105. PubMed ID: 7724979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical case of the month. Porto-pulmonary hypertension syndrome associated with severe hypoxemia].
    Kolan C; Ghuysen A; Lambermont B; D'Orio V
    Rev Med Liege; 2001 Aug; 56(8):543-7. PubMed ID: 11584437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboendarterectomy as treatment in the antiphospholipid syndrome.
    Peng SW; Mitchell JP
    MedGenMed; 2006 Jul; 8(3):7. PubMed ID: 17406149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
    Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
    Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical risk factors for portopulmonary hypertension.
    Kawut SM; Krowka MJ; Trotter JF; Roberts KE; Benza RL; Badesch DB; Taichman DB; Horn EM; Zacks S; Kaplowitz N; Brown RS; Fallon MB;
    Hepatology; 2008 Jul; 48(1):196-203. PubMed ID: 18537192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension as the presenting feature of the antiphospholipid syndrome.
    Karim MY; Alba P; Tungekar MF; Abbs IC; Khamashta MA; Hughes GR; Hunt BJ
    Lupus; 2002; 11(4):253-6. PubMed ID: 12043890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late complications of biliary atresia: hepatopulmonary syndrome and portopulmonary hypertension.
    Karrer FM; Wallace BJ; Estrada AE
    Pediatr Surg Int; 2017 Dec; 33(12):1335-1340. PubMed ID: 28983709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary antiphospholipid syndrome and pulmonary hypertension.
    Mirrakhimov AE; Hill NS
    Curr Pharm Des; 2014; 20(4):545-51. PubMed ID: 23565637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portopulmonary hypertension in a patient of autoimmune hepatitis.
    Hira HS; Gupta M; Tyagi SK
    Indian J Chest Dis Allied Sci; 2005; 47(2):127-30. PubMed ID: 15832959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies.
    De Clerck LS; Michielsen PP; Ramael MR; Janssens E; Van Maercke YM; Van Marck EA; Stevens WJ
    J Rheumatol; 1991 Dec; 18(12):1919-21. PubMed ID: 1795332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac manifestations of the antiphospholipid syndrome.
    Asherson RA; Cervera R
    Coron Artery Dis; 1993 Dec; 4(12):1137-43. PubMed ID: 8162248
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiphospholipid antibodies and splenic thrombosis in a patient with idiopathic myelofibrosis (antiphospholipid antibodies and thrombosis).
    Bregani ER; Corneo G; Pogliani EM
    Haematologica; 1992; 77(6):516-7. PubMed ID: 1289189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How should we treat portopulmonary hypertension?
    Krowka MJ; Swanson KL
    Eur Respir J; 2006 Sep; 28(3):466-7. PubMed ID: 16946090
    [No Abstract]   [Full Text] [Related]  

  • 40. Review: antiphospholipid antibodies and the lung.
    Asherson RA; Cervera R
    J Rheumatol; 1995 Jan; 22(1):62-6. PubMed ID: 7699684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.